AKUNA SECURITIES LLC
Institutional investor · Portfolio as of Q4 2025
Top Holdings25 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
| 12.6M | $7.7B | 29.5% | — | — | — | Increased — | |
| 9.2M | $6.3B | 23.8% | — | — | — | Decreased — | |
| 8.3M | $5.7B | 21.6% | — | — | — | Decreased — | |
| 7.1M | $4.4B | 16.7% | — | — | — | Increased — | |
| 2.9M | $717.1M | 2.7% | — | — | — | Increased — | |
| 1.9M | $473.6M | 1.8% | — | — | — | Increased — | |
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 361,344 | $246.4M | 0.9% | $604.57 | +13.64% | 5 qtrssince 2024-Q4 | Decreased 0 |
| 1.2M | $216.2M | 0.8% | — | — | — | Increased — | |
| 953,500 | $177.8M | 0.7% | — | — | — | Increased — | |
| 295,000 | $132.7M | 0.5% | — | — | — | New — | |
| 212,900 | $95.7M | 0.4% | — | — | — | New — | |
| 1.6M | $80.5M | 0.3% | — | — | — | Decreased — | |
| 788,800 | $39.2M | 0.1% | — | — | — | Decreased — | |
NVIDIA CORP | 42,125 | $7.9M | 0.0% | $187.54 | 0.00% | 1 qtr | New 41 |
| 27,400 | $5.9M | 0.0% | — | — | — | New — | |
| 25,400 | $5.4M | 0.0% | — | — | — | New — | |
ISHARES BITCOIN TRUST | 38,926 | $1.9M | 0.0% | $64.49 | -22.73% | 3 qtrssince 2025-Q2 | Decreased 0 |
PROSHARES TR | 16,850 | $888,332 | 0.0% | $54.10 | 0.00% | 1 qtr | New 37 |
ISHARES CORE S&P 500 ETF | 1,074 | $735,626 | 0.0% | $689.92 | +12.52% | 1 qtr | New 37 |
PROSHARES TR | 4,809 | $556,690 | 0.0% | $118.44 | 0.00% | 1 qtr | New 37 |
AKUNA SECURITIES LLC manages $26.2B across 25 positions as of Q4 2025. Top holdings: INVESCO QQQ TRUST SERIES I (29.5%), STATE STREET SPDR S&P 500 ETF (23.8%), STATE STREET SPDR S&P 500 ETF (21.6%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 9 new positions, 1 exits, 0 increased. Top move: NVDA (NEW, conviction 41). Portfolio: $26.2B across 25 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer